Dylan Vaughan

Dylan Vaughan started their work experience in 2015 as a Research Assistant at Boston Children's Hospital, where they focused on researching the pathogenicity of genetic and teratogenic forms of microcephaly. In 2017, they moved on to Zymergen and held various roles, including Research Associate I, Research Associate II, Research Associate III, and eventually became a Senior Research Associate in 2021. At Zymergen, their work involved scientific research and experimentation. In 2022, Dylan joined Cambrium as a Bioprocessing Scientist, where they contribute to a team of specialists in designing a material future without compromise using the molecular programmability of proteins.

Dylan Vaughan attended Boston University from 2011 to 2015, where they obtained a Bachelor's degree in Biochemistry and Molecular Biology.